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B lymphocytes are equipped with a receptor for the recognition of the Fc part of IgG (1, 
2) which is not identical to the surface Ig receptor (3). Dickler and Sachs (4) found that 
anti-Ia antibodies inhibit the binding of aggregated IgG to this receptor, whereas anti-H- 
2D or K antibodies did not have the same effect. On the other hand, Schirrmacher et al. 
(5) found that also antibodies against other B-lymphocyte surface constituents than Ia 
could interfere with the Fc receptor. However, the Ia antigens are probably not part of  the 
Fc receptor molecule (6), and the observed inhibition may best be explained by a close 
association between Fc receptors and the Ia antigens in the B-cell membrane. Since Ia 
antibodies do not inhibit the Fc receptors of macrophages or fetal liver cells  (7), the 
association between Ia and Fc on these cells may be less pronounced. 
We have investigated the relationship between HLA antigens and Fc recep- 
tors on human lymphoid cells. The inhibitory activity of different HLA antisera 
on cells forming rosettes with antibody-coated erythrocytes (FcRFC) and K-cell 
cytotoxicity was studied with  antisera  recognizing determinants  coded for by 
different regions of the HLA  chromosomal complex.  The HLA-A,  -B,  and -C 
regions are the human analogues of the mouse H-2D  and H-2K regions, while 
the HLA-D  region codes for mixed lymphocyte culture (MLC)-activating deter- 
minants which may be analogues to some of the mouse Ia antigens. 
Materials  and Methods 
Antisera.  Serum EA from a multiparous woman is specific for HLA-B7 in lymphocytotoxicity 
tests and does not contain detectable antibodies specific for HLA-Dw2-associated  B-cell antigens. 
Rabbit antihuman/3-2-microglobulin  (/3-2-m) (10-U72; Dakopatts A/S, DK-2000 Copenhagen F, 
Denmark) was used,  since it is part of the HLA-A, -B and -C, but not the HLA-D-associated 
molecules in the cell membrane (8, 9). Antisera reactive with determinants  of the HLA-D region 
were sought by immunization in HLA-A, -B (and -C?)-compatible, but HLA-D-incompatible  MLC- 
positive unrelated  combinations. Serum producer SSW is HLA-1A,3;  B7,8; Dw3,Ld-oh, and TH is 
A2,3; B7,12; Dwl,2; their immunizing  donors are  A1,3; B7,8; Dw2,3, and A2,3; B7,12; Dw6,x, 
respectively. Details of these sera are presented elsewhere (8). They are reactive with human B 
lymphocytes and monocytes in cytotoxicity and immunofluorescence tests, but not with normal T 
lymphocytes. Serum SSW reacts with a determinant  which, in population studies, is very closely 
associated to HLA-Dw2, while serum  TH may be directed  against a more public determinant 
including HLA-Dw3,  -Dw6, and others. 
Rabbit antihuman IgG (10-090) and antihuman IgG-Fc fragment-specific (10-00G) and swine 
antirabbit  IgG (21-090) were all delivered as isolated immunoglobulins by Dakopatts A/S. They 
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were excessively absorbed with sheep red blood cells (SRBC) to remove heteroantibodies. 
F(ab')2 Fragments.  F(ab')2 fragments of serum SSW, TH, and EA were prepared by pepsin (2 
× crystallized and lyophilized; activity 2,500-3,200 U/mg protein, Sigma Chemical Co., St. Louis, 
Mo.) digestion of IgG fractions at 37°C pH 4.2 in 0.1 N  acetate buffer for 24 h  at enzyme/pretein 
ratio of 2:100.  IgG was isolated from antiserum by salting out and batch absorption with DEAE 
Sephadex A50 equilibrated with 0.1 M Tris buffer pH 8.0.  By double diffusion in 1% agarose, no 
precipitin lines were detectable with Fc-specific anti-IgG, while the reaction with anti-IgG was 
unaltered. Fab' fragments were prepared by reduction and alkylation of the F(ab')2 fragments by 
dialysis at 4°C against 0.2 M 2-mercaptoethanol followed by 0.001  M iodoacetamide (10).  F(ab')2 
fragments  of rabbit  antihuman  IgG,  rabbit  antihuman  ~-2-m and  swine  antirabbit  IgG were 
prepared  by  digesting  the  immunoglobulin  preparations  under  conditions  identical  to  those 
applied to human IgG. The precipitating activity in agarose gel was identical for F(ab')2-anti-fl-2- 
m and original anti-fl-2-m when tested against fl-2-m. 10 ml of serum resulted in the production of 
2.5 ml F(ab')2 fragments, while no significant volume changes occurred when IgG preparations 
were digested.  All sera  were ultracentrifuged  immediately before use,  for elimination of IgG 
aggregates. 
HLA  Typing.  Mononuclear  cells  were  prepared  from  fresh  defibrinated  blood  by  Ficoll- 
isopaque flotation (11). HLA-A, -B, and -C typing was performed with 54 highly selected sera by 
the microcytotoxicity test (12).  HLA-D typing was performed by the use of HLA-D homozygous 
stimulating cells (13). Typing with serum SSW and TH was performed by microlymphocytotoxic- 
ity tests using as target cells lymphocytes enriched for B cells (8). 
Production oflgG-Coated SRBC.  SRBC, washed three times with phosphate-buffered saline, 
were made up to a 1% suspension. The IgG fraction of rabbit anti-SRBC, produced by Sephadex G- 
200 column chromatography, was diluted to the subagglutinating concentration 1/320 and mixed 
with the red cells and incubated at room temperature for 60 min. Thereafter, red cells were washed 
and resuspended to 1% suspension in balanced salt solution (BSS). 
Inhibition of  FcRFC by Antisera.  2 x  10  e peripheral blood mononuclear cells were mixed with 
antiserum, diluted 1/2, 1/100 (as indicated) in a total vol of 0.2 ml and incubated for 30 min at +4°C. 
thereafter,  the cells were washed  once  in  ice-cold buffer  and  resuspended  in  0.5  ml  BSS.  In 
instances where two different antisera were used in consecutive steps for inhibition, both incuba- 
Lions were carried out at +4°C for 30 min with cell washes in between. Rosettes were allowed to 
Form by the addition of 0.1 ml of antibody-coated 1% SRBC to 0.5 ml BSS containing 2 ×  108 cells. 
the cell mixture was spun in the cold at 800 rpm for 10 min and thereafter put on ice for another 30 
min before examination for the number of rosettes in a light microscope at 400  x  magnification. 
All cells binding five or more red cells were considered positive. At least 200 lymphocytes were 
scored in each cell suspension. 
Inhibition of  K-Cell Cytotoxicity.  Antibody-dependent cell-mediated cytotoxicity (ADCC) was 
performed  as  a  micro-method  (14)  with  an  HLA-B27  antiserum  (serum  FJH)  as  sensitizing 
antibody and human peripheral blood lymphocytes as target cells. Peripheral blood mononuclear 
cells which did not carry HLA-B27 and which were depleted of adherent cells by incubation in a 
3024 Falcon plastic flask (Falcon Plastics, Oxnard, Calif.) for 60 min at 37°C were used as effector 
cells. 
Effector cells (105 in triplicates) were incubated at 4°C for 30 min with 0.15 ml antibody diluted 
i/3,  1/100,  as  indicated  on  the  tables,  in  medium  (RPMI  1640 added  10%  fetal  calf serum). 
thereafter the superuate was pipetted off, the cells washed once with ice-cold medium,  0.1  ml 
medium with sensitizing antibody was added, and then 5 × 10  ~ 51Cr-labeled target cells were jetted 
into the wells in a vol of 0.05 ml. Samples were then incubated at 37°C for 16 h in humidified CO2 
atmosphere,  harvested with a  semiautomatic harvesting machine (Skatron A]S, Lierbyen, Nor- 
way), and chromium release measured in a  well type Packard Auto-Gamma Scintillation Spec- 
Lrometer (Model $78).  The percent chromium release was calculated by the formula (ER-SR)/(MR- 
~R) ×  100, where ER is experimental release; SR is spontaneous release in the presence of effector 
~ells without antiserum; MR is maximum release obtained by adding Cetavlon (Imperial Chemi- 
.'al Industries Ltd., Cheshire, England) to a final concentration of 5% to the target cells. 
Results 
Inhibition of FcRFC.  Mononuclear cells were pretreated with various sera 
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results of one experiment are shown in Table I. Pretreatment  with anti-HLA-B7 
serum did not interfere with Fc rosette formation, neither by FcRFC carrying 
HLA-B7,  nor by those lacking this antigen.  However, serum SSW  inhibited 
rosette formation only by FcRFC carrying Dw2,  whereas serum TH did not 
affect the HLA-Dw2 carrying FcRFC, but inhibited the FcRFC from the other 
donor. Inhibition was found in serum dilution up to hl0 (cytotoxic titer: 1/2). 
Altogether, FcRFC from six different individuals were tested with serum SSW. 
Inhibition of FcRFC  was caused by serum SSW  on all the four target cells 
carrying Dw2, but not on other cells. 
Inhibition of  FcRFC by Antibody Fragments.  F(ab')2 fragments from serum 
SSW were tested. Table II shows that F(ab')2  from serum SSW caused a weak 
but significant inhibition of the two Dw2-positive donors, but had no effect on 
the Dw2-negative FcRFC.  Fab'  fragments were not inhibitory. However, the 
addition of F(ab')2  antihuman IgG as a second treatment of the cells increased 
the inhibitory capacity of dimeric antibody fragments and also caused inhibition 
by monomeric antibody fragments. The additive effect was most pronounced on 
monomeric antibody fragments. F(ab')2  anti-IgG antibody alone did not inter- 
fere with Fc rosette formation. 
The effect of anti-fl-2-m was also investigated. No effect on FcRFC could be 
detected. Furthermore, F(ab')2  fragments against rabbit IgG were used in an 
attempt  to  enhance a  possible  inhibitory effect of anti-fl-2-m,  but  without 
SUCceSS. 
Inhibition of  K-Cell Cytotoxicity.  Effector lymphocytes  selected for the pres- 
ence or absence of HLA-B7, Dw2, and Dw3, were used. Table HI summarizes the 
results. Serum SSW and TH induced some HLA-D-correlated inhibition of the 
effector cells,  but a  stronger inhibition was observed with the anti-HLA-B7 
antibodies on the HLA-B7-positive effector cells. Anti-~-2-m gave marked inhi- 
bition of all tested effector cells. 
Experiments were also performed with F(ab')2 fragments. None of the F(ab')2 
fragments demonstrated any inhibitory activity although they were reactive 
with the  relevant antigens when tested by immunofluorescence. Thus,  the 
inhibition of K-cell cytotoxicity seems to depend upon an intact Fc part in the 
blocking antibody. 
Discussion 
Striking differences in  the  ability of HLA  antisera to  inhibit Fc  rosette- 
forming cells and K-cell cytotoxicity were demonstrated. Antisera recognizing 
HLA-A,  -B,  and -C  antigens had no inhibitory effect on FcRFC,  while two 
antisera,  which may recognize determinants identical to  or associated with 
those of the HLA-D series,  specifically inhibited FcRFC.  Inhibition,  though 
somewhat decreased, was also expressed by the F(ab')2  fragments, while Fab' 
alone was  inactive.  Subsequent treatment of the  Fab'-incubated cells with 
F(ab')2 anti-IgG produced specific inhibition. 
The Fc part of the shed AgAb complexes appears  not to be the main inhibitory 
component. The experiments were performed under conditions  where the cell membrane 
was rigid (4°C), and only antigens with very weak attachment to the membrane could 
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TABLE I 
Inhibition  of FcRFC by Serum S6W and TH but not by Anti-HLA-B7 
Antibodies 
Serum  Dilution 
FcRFC + with cells  from 
donor with HLA phenotype 
A3;B7;Dw2  A3,w19; 
B12,wl5;Dw4,x 
None  35  35 
Normal AB serum  1/2  34  35 
Anti.HLA-B7 (EA)  1/2  36  34 
1/10  33  36 
Serum S~W 
Serum TH 
1/2  9  35 
1/10  11  35 
1/100  32  bit 
1/2  33  18 
1/10  30  17 
1/100  NT  29 
I~F, not treated. 
TABLE II 
Inhibition  of FcRFC by Antibody Fragments of Serum S6W 
First  treatment  Second treatment 
FcRFC + with + ceils 
with phenotypes 
A2,3;  A1,2;B7,8;  A3;B7; 
B12,w35; 
Dwl,x  Dw2,x  Dw2,x 
%  %  % 
Normal serum  Normal serum  37  29  33 
Normal serum  F(ab')2  antihuman IgG  33  23  38 
S6W F(ab')2  Normal serum  37  19  26 
S~W F(ab')2  F(ab')~  antihuman IgG  35  13  24 
S6W Fab'  Normal serum  NT  29  40 
SSW Fab'  F(ab')s antihuman IgG  38  15  29 
NT,  not treated. 
HLA-A, -B, -C, and probably -D associated antigens to lymphocyte membranes (8, 15). 
The reason that F(ab')2 fragments are less efficient, and that Fab' are inefficient may be 
due to the fact that the serum SSW is low in titer,  and that the antibodies have low 
avidity (8). Thus a  much decreased binding may be expected by the Fab' fragments. 
Inhibition after "coating" with F(ab')2 anti-IgG can be due either to decreased dissocia- 
tion from the cells,  increased steric hindrance, or beth.  Schirrmacher et al.  (5) in the 
mouse system also found that F(ab')2 fragments were less effective. 
Our results indicate that the antigenic determinants recognized by our two antisera, 
S6W and TH, are closely associated with the Fc receptor in the lymphocyte membrane, 
and that the inhibition therefore may be caused by steric hindrance. Others (16, 17) have 
also recently reported that the Fc receptors on human lymphocytes and B-lymphoid cell 
lines are closely associated with determinants recognized with some B-cell alloantisera. 
In MLC reactions, we have shown that serum S6W (18) and serum TH  ~ demonstrate a 
D. Albrechtsen, B. G. Solheim, and E. Thorsby. Antiserum  inhibition of the mixed lympho- 
cyte culture  (MLC) interaction.  I. Inhibitory  effect of antisera reactive with HLA-D associated 
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TABLE  III 
Inhibition of ADCC by Intact IgG Antibodies. Sensitizing Antibody, Anti-HLA-B27; 
Preincubation of Effector Cells with Anti-HLA-B7, Anti-~-2-m,  Serum SdW, or Serum 
TH 
Effector cell HLA type 
Preincubation  serum  Dilution  A2,9;B7,w15;  A1;B8;Dw3  Al,w29;B8,12; 
Dw2,x  Dw3,107 
TI*  T2  T1  T2  T3  T4 
Normal AB serum  1/3  63¢  40  53  34  25  46 
Serum S~W  1/3  21  25  53  39  29  50 
Serum TH  1/3  35  19  8  20  11  21 
1/25  NT  NT  NT  NT  20  31 
Anti-HLA-B7  1/25  14  8  53  51  35  60 
1/100  30  31  NT  NT  NT  NT 
Anti-B-2-m  1/25  -11  20  -3  10  12  13 
1/100  NT  NT  NT  NT  17  14 
* Target 1: A9; B13,  27; DwS, 6  (SR 101  [counts per minute],  MR 441).  Target 2: A9, 11; B27,  w35;  Cw2, 3; LD 107, x  (SR 256, 
MR 1,145). Target 3: A1, 2; B5, 27; Cw2; Dw6,x (SR 520, MR 2,032). Target 4: A2, w19; BS, 27; Cw2; Dw2, 108 (SR 102, MR 316). SR, 
spontaneous release; MR, maximal release. 
¢ Percent S~Cr release calculated from medians. 
strong and specific inhibition of the stimulating cells. Studies by Meo et al.  (19) in the 
mouse have revealed that some of the Ia antigens may be major MLC-activating deter- 
minants in this species. Thus, the association between the Fc receptor  and the deter- 
minants recognized by the SSW and TH antisera is further evidence that these deter- 
minants may be human analogues of the mouse Ia antigens. 
Both anti-HLA-A, -B, and -C antibodies and serum SSW and TH were able to inhibit 
K-cell cytotoxicity. No inhibition could be observed with the F(ab')2 fragments of the 
antibodies,  indicating that the Fc part was responsible for the inhibitory activity. The 
test was performed at 37°C for 16 h, conditions that promote aggregation of the antigens 
in the cell membrane and shedding. Thus, a steric hindrance of the Fc receptor might be 
reversed. This makes it difficult to determine the association between Fc receptor on K 
cells and HLA determinants in the ADCC system.  Inhibition by intact IgG antibodies 
only may be due to the effect of aggregated or shed AgAb complexes with an intact Fc 
portion. 
Our results are parallel to the findings in the mouse by Schixi~nacher et al. (5) 
that the effector cells in an ADCC assay are inhibited by intact anti-H-2D, K, 
and Ia antibodies, but not by F(ab')2 fragments thereof. 
Anti-HLA-B7 and anti-/3-2-m were unable to inhibit FcRFC, which agrees 
well with the observations in mice by Dickler and Sachs (4) and Krammer and 
Pernis (7), who report that anti-Ia, but not anti-H-2D- or -K-specific antisera, 
could inhibit FcRFC. Thus, inhibition of Fc rosette formation may be an easy 
and specific screening method for detection of antibodies recognizing HLA-D- 
associated (human Ia?) determinants. 
Summary 
The inhibitory effect ofHLA antisera on Fc receptors of  human lymphoid cells 
was investigated. The ability of lymphoid cells to form rosettes (FcRFC) with 
antibody-coated sheep red blood cells and to function as effector cells (K cells) in SOLHEIM  ET  AL.  BRIEF  DEFINITIVE  REPORT  1573 
antibody-dependent cell-mediated cytotoxicity were used as assay systems. We 
found that antisera recognizing determinants of the HLA-A, -B, and -C series 
had  no  effect on  FcRFC,  while a  specific  inhibitory effect was  observed  of 
antisera probably reacting with determinants identical to or closely associated 
with those of  the HLA-D series. This inhibitory effect was retained in the F(ab')2 
fragments. Specific inhibition of K  cells was observed with all HLA antisera, 
but  this  effect was  lost in the  F(ab')~  fragments.  We  conclude that the  Fc 
receptor of rosette-forming lymphocytes  may be closely associated with products 
of the HLA-D  region.  This  is  analogous to  the  association between the  Fc 
receptor and the Ia antigens on murine rosette-forming B lymphocytes. 
We are  indebted to M~rit Larsson and Edith Kiss for excellent technical assistance. Mrs. 
Elizabeth Garmann kindly helped in the preparation of the manuscript. 
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